Skip to main content
. 2019 Jun 1;199(11):1385–1396. doi: 10.1164/rccm.201807-1220OC

Table 4.

Weighted* Odds Ratios and 95% Confidence Intervals of FEV1% Predicted Quartile with Dementia, MCI, Alzheimer’s Disease–Type Dementia or MCI, and Dementia or MCI Caused by Cerebrovascular Disease: ARIC Study, 1987–2013

  FEV1% Predicted
  Quartile 1 Quartile 2 Quartile 3 Quartile 4 Trend (per 1 SD Decrease)
n 1,473 1,471 1,472 1,473  
Dementia or MCI, n 450 364 346 378  
 Model 1 1.38 (1.15–1.65) 1.02 (0.85–1.23) 0.92 (0.77–1.11) 1 1.14 (1.07–1.22)
 Model 2 1.35 (1.12–1.63) 1.01 (0.84–1.22) 0.92 (0.77–1.11) 1 1.13 (1.06–1.21)
 Model 3 1.27 (1.05–1.54) 0.97 (0.80–1.17) 0.89 (0.73–1.07) 1 1.11 (1.04–1.20)
 Model 4 1.26 (1.04–1.53) 0.96 (0.79–1.16) 0.88 (0.73–1.06) 1 1.11 (1.03–1.19)
Dementia, n 87 59 69 83  
 Model 1 1.33 (0.91–1.93) 0.88 (0.59–1.30) 0.95 (0.65–1.40) 1 1.10 (0.97–1.26)
 Model 2 1.23 (0.83–1.81) 0.85 (0.57–1.27) 0.95 (0.65–1.39) 1 1.06 (0.93–1.22)
 Model 3 1.09 (0.73–1.65) 0.77 (0.50–1.18) 0.90 (0.61–1.33) 1 1.03 (0.89–1.20)
MCI, n 363 305 277 295  
 Model 1 1.41 (1.16–1.71) 1.08 (0.89–1.31) 0.93 (0.77–1.14) 1 1.16 (1.08–1.24)
 Model 2 1.41 (1.16–1.72) 1.08 (0.89–1.32) 0.94 (0.77–1.14) 1 1.16 (1.08–1.25)
 Model 3 1.34 (1.10–1.64) 1.04 (0.85–1.27) 0.90 (0.74–1.10) 1 1.14 (1.06–1.23)
AD-type dementia or MCI, n 284 223 237 260  
 Model 1 1.23 (1.00–1.52) 0.91 (0.73–1.13) 0.91 (0.74–1.13) 1 1.09 (1.01–1.18)
 Model 2 1.26 (1.01–1.56) 0.92 (0.74–1.15) 0.92 (0.74–1.13) 1 1.10 (1.01–1.19)
 Model 3 1.23 (0.98–1.54) 0.90 (0.72–1.13) 0.89 (0.72–1.10) 1 1.10 (1.01–1.19)
Cerebrovascular dementia or MCI, n 57 53 35 43  
 Model 1 1.84 (1.18–2.88) 1.33 (0.85–2.07) 0.97 (0.58–1.60) 1 1.33 (1.14–1.55)
 Model 2 1.58 (1.02–2.46) 1.26 (0.80–1.97) 0.95 (0.57–1.57) 1 1.25 (1.08–1.44)
 Model 3 1.43 (0.91–2.24) 1.15 (0.72–1.83) 0.90 (0.54–1.49) 1 1.23 (1.05–1.43)

Definition of abbreviations: AD = Alzheimer’s disease; ARIC = Atherosclerosis Risk in Communities; MCI = mild cognitive impairment.

Model 1: Logistic regression adjusted for age, sex, center, education level, and race–center (five-level variable). Model 2: model 1 + additional adjustment for cigarette smoking and pack-years of smoking. Model 3: model 2 + additional adjustment for physical activity, body mass index, systolic blood pressure, blood pressure medication use, diabetes, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, lipid-lowering medications, prevalent coronary heart disease, heart failure, stroke, and apolipoprotein E genotype. Model 4: model 3 + fibrinogen.

*

Inverse-probability weighting was used.